125 related articles for article (PubMed ID: 18798070)
1. Do single nucleotide polymorphisms in xenobiotic metabolizing genes determine breast cancer susceptibility and treatment outcomes?
Singh V; Parmar D; Singh MP
Cancer Invest; 2008 Oct; 26(8):769-83. PubMed ID: 18798070
[TBL] [Abstract][Full Text] [Related]
2. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.
Chacko P; Joseph T; Mathew BS; Rajan B; Pillai MR
Mutat Res; 2005 Mar; 581(1-2):153-63. PubMed ID: 15725614
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in xenobiotic-metabolizing genes and the risk of chronic lymphocytic leukemia and non-Hodgkin's lymphoma in adult Russian patients.
Gra OA; Glotov AS; Nikitin EA; Glotov OS; Kuznetsova VE; Chudinov AV; Sudarikov AB; Nasedkina TV
Am J Hematol; 2008 Apr; 83(4):279-87. PubMed ID: 18061941
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms of metabolic enzymes CYP1A1, CYP2D6, GSTM1 and GSTT1 and leukemia susceptibility.
Chen HC; Hu WX; Liu QX; Li WK; Chen FZ; Rao ZZ; Liu XF; Luo YP; Cao YF
Eur J Cancer Prev; 2008 Jun; 17(3):251-8. PubMed ID: 18414197
[TBL] [Abstract][Full Text] [Related]
5. Xenobiotic-metabolizing enzymes and cancer risk: correspondence between genotype and phenotype.
Pelkonen O; Raunio H; Rautio A; Lang M
IARC Sci Publ; 1999; (148):77-88. PubMed ID: 10493250
[TBL] [Abstract][Full Text] [Related]
6. Methylenetetrahydrofolate reductase haplotype tag single-nucleotide polymorphisms and risk of breast cancer.
Martin YN; Olson JE; Ingle JN; Vierkant RA; Fredericksen ZS; Pankratz VS; Wu Y; Schaid DJ; Sellers TA; Weinshilboum RM
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2322-4. PubMed ID: 17119067
[No Abstract] [Full Text] [Related]
7. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers.
Zienolddiny S; Campa D; Lind H; Ryberg D; Skaug V; Stangeland LB; Canzian F; Haugen A
Carcinogenesis; 2008 Jun; 29(6):1164-9. PubMed ID: 18258609
[TBL] [Abstract][Full Text] [Related]
8. Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmö Diet and Cancer cohort.
Ericson U; Sonestedt E; Ivarsson MI; Gullberg B; Carlson J; Olsson H; Wirfält E
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1101-10. PubMed ID: 19336565
[TBL] [Abstract][Full Text] [Related]
9. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer.
Sachse C; Smith G; Wilkie MJ; Barrett JH; Waxman R; Sullivan F; Forman D; Bishop DT; Wolf CR;
Carcinogenesis; 2002 Nov; 23(11):1839-49. PubMed ID: 12419832
[TBL] [Abstract][Full Text] [Related]
10. [Using MSR model to analyze the impact of gene-gene interaction with related to the genetic polymorphism of metabolism enzymes on the risk of breast cancer].
Li JY; Long QM; Tao P; Hu R; Li H; Lei FM; Zhou WD; Li SF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):780-3, 787. PubMed ID: 19024313
[TBL] [Abstract][Full Text] [Related]
11. Dihydrofolate reductase (DHRF) 19-bp intron-1 deletion and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms in breast cancer.
Cam R; Eroglu A; Egin Y; Akar N
Breast Cancer Res Treat; 2009 May; 115(2):431-2. PubMed ID: 18498051
[No Abstract] [Full Text] [Related]
12. How valid is single nucleotide polymorphism (SNP) diagnosis for the individual risk assessment of breast cancer?
Tempfer CB; Hefler LA; Schneeberger C; Huber JC
Gynecol Endocrinol; 2006 Mar; 22(3):155-9. PubMed ID: 16835078
[TBL] [Abstract][Full Text] [Related]
13. Additive effects of genetic variations of xenobiotic detoxification enzymes and DNA repair gene XRCC1 on the susceptibility to breast cancer.
Masoudi M; Saadat I; Omidvari S; Saadat M
Breast Cancer Res Treat; 2010 Feb; 120(1):263-5. PubMed ID: 19731014
[No Abstract] [Full Text] [Related]
14. Diet, genetic polymorphisms, detoxification, and health risks.
Lampe JW
Altern Ther Health Med; 2007; 13(2):S108-11. PubMed ID: 17405687
[TBL] [Abstract][Full Text] [Related]
15. Combination of TNF-RII, CYP1A1 and GSTM1 polymorphisms and the risk of Japanese SLE: findings from the KYSS study.
Horiuchi T; Washio M; Kiyohara C; Tsukamoto H; Tada Y; Asami T; Ide S; Kobashi G; Takahashi H;
Rheumatology (Oxford); 2009 Sep; 48(9):1045-9. PubMed ID: 19561157
[TBL] [Abstract][Full Text] [Related]
16. Single nucleotide polymorphisms and breast cancer: not yet a success story.
Tamimi RM
Breast Cancer Res; 2006; 8(4):108. PubMed ID: 16887007
[TBL] [Abstract][Full Text] [Related]
17. Association studies of CYP1A1 and GSTM1 polymorphisms with esophageal cancer risk: evidence-based meta-analyses.
Zhuo WL; Zhang YS; Wang Y; Zhuo XL; Zhu B; Cai L; Chen ZT
Arch Med Res; 2009 Apr; 40(3):169-79. PubMed ID: 19427967
[TBL] [Abstract][Full Text] [Related]
18. Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study.
Küry S; Buecher B; Robiou-du-Pont S; Scoul C; Colman H; Le Neel T; Le Houérou C; Faroux R; Ollivry J; Lafraise B; Chupin LD; Sébille V; Bézieau S
BMC Cancer; 2008 Nov; 8():326. PubMed ID: 18992148
[TBL] [Abstract][Full Text] [Related]
19. An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: a HuGE review.
Mo Z; Gao Y; Cao Y; Gao F; Jian L
Prostate; 2009 May; 69(6):662-88. PubMed ID: 19143011
[TBL] [Abstract][Full Text] [Related]
20. Lack of influence of glutathione S-transferase genotype profile on cancer susceptibility in smokers and nonsmokers.
Sampaio AC; Morari EC; Bufalo NE; Leite JL; Lima CS; Ward LS
Med Sci Monit; 2009 Jan; 15(1):CR10-5. PubMed ID: 19114965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
